This review discusses acne vulgaris and the rationale for use of anti-androgen medications in its treatment before summarising key pharmacological and clinical trials evidence supporting use of the first-in-class topical anti-androgen medication clascoterone 1% cream in the treatment of acne in adolescents and adults. This review is sponsored by Douglas Pharmaceuticals Ltd.
Please login below to download this issue (PDF)